Daniel Heyler analyst CITI

Currently out of the existing stock ratings of Daniel Heyler, 2 are a BUY (50%), 2 are a SELL (50%).

Daniel Heyler

Work Performance Price Targets & Ratings Chart

Analyst Daniel Heyler, currently employed at CITI, carries an average stock price target met ratio of 100% that have a potential upside of 76.79% achieved within 1838 days. Previously, Daniel Heyler worked at NORTHCOAST.

Daniel Heyler’s has documented 7 price targets and ratings displayed on 1 stocks. The coverage is on the Technology sector.

Most recent stock forecast was given on HIMX, Himax Technologies at 23-Sep-2015.

Wall Street Analyst Daniel Heyler

Analyst best performing recommendations are on HIMX (HIMAX TECHNOLOGIES).
The best stock recommendation documented was for HIMX (HIMAX TECHNOLOGIES) at 6/10/2015. The price target of $8.5 was fulfilled within 895 days with a profit of $3.43 (67.65%) receiving and performance score of 0.76.

Average potential price target upside

HIMX Himax Technologies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Oct-2017

$15

9 months 28 days ago
(05-Dec-2025)

22/22 (100%)

$6.89 (84.96%)

884

Hold Since 14-Jul-2022

$7

3 years 1 months 22 days ago
(11-Aug-2023)

3/3 (100%)

$1.39 (24.78%)

1311

Buy Since 27-Jan-2021

$11

$-4.24 (-27.82%)

4 years 5 months 26 days ago
(07-Apr-2022)

9/9 (100%)

$3.85 (53.85%)

1227

Sell Since 17-Sep-2021

$7.5

$-0.59 (-7.29%)

$12.4

5 years 16 days ago
(17-Sep-2021)

2/2 (100%)

$-0.53 (-6.60%)

70

Buy Since 08-Feb-2021

$13

$-2.24 (-14.70%)

$4.5

5 years 7 months 25 days ago
(08-Feb-2021)

5/5 (100%)

$2.14 (19.71%)

821

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Daniel Heyler?

On 2014
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?